Memphasys Ltd has released a press release.
A$2 million capital raising
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Voluntary Suspension
- Response to ASX Query
- Equine fertility study positions Felix as leading technology
- Felix sales clinical trial and Oxidative Stress devel update
- Animal activity update - oxidative stress measurement system
Later from Memphasys
- Positive initial study results - Felix equine application
- Short term loan facility
- Prospectus
- Equine study commences with 12mth commercialisation expected
- Felix Trial registration update
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys